Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment for postoperative recurrent EGFR-mutated lung adenocarcinoma: a multi-institutional retrospective study.
Ryo Miyata; Masatsugu Hamaji; Atsushi Kawaguchi; Yumeta Shimazu; Masaki Ikeda; Masashi Ishikawa; Hidenao Kayawake; Toshi Menju; Masashi Kobayashi; Norihito Okumura; Yasuto Sakaguchi; Makoto Sonobe; Akira Matsumoto; Tsuyoshi Shoji; Hiromichi Katakura; Ryota Sumitomo; Cheng-Long Huang; Mamoru Takahashi; Akihiro Aoyama; Yusuke Muranishi; Tomoya Kono; Ryo Miyahara; Naoki Date; Takuji Fujinaga; Ei Miyamoto; Tatsuo Nakagawa; Takahisa Fukada; Hiroaki Sakai; Hiroshi Date
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2022年10月04日